10 Best Small Company Stocks To Invest In

Page 9 of 9

1. Dianthus Therapeutics, Inc. (NASDAQ:DNTH)

Market Capitalization: $572.126 million

Upside potential as of June 18, 2025: 188.91%

Stifel reaffirmed a Buy rating on Dianthus Therapeutics, Inc. (NASDAQ:DNTH) while maintaining a price target of $52.00, citing the strength of the company in keeping more cash than debt. This impressive upside of 186.3%, from the current price of $18.02, shows that the giant is heading north as it develops lead drug candidate DNTH103.

The discussion revolved around the design of DNTH103 and its anticipated Phase 2 trial results for myasthenia gravis (MG), which is expected in September 2025. The management believes the success of DNTH103, relative to C5 inhibitors in the MG trial, would translate to the success of Dianthus Therapeutics, Inc. (NASDAQ:DNTH), driven by the drug’s improved safety profile and straightforward dosing schedule through a biweekly autoinjector.

Big changes are expected in the near future. The company is working to test DNTH103 in chronic inflammatory demyelinating polyneuropathy (CIDP), with interim results forecasted for the second quarter of 2026. If the MG trial goes well, this study will clear the path for a follow-up Biologics License Application.

Dianthus Therapeutics, Inc. (NASDAQ:DNTH), founded in 2019, is a New York-based clinical-stage biotechnology company that develops complement therapeutics for patients living with autoimmune and inflammatory diseases. With a commitment to leverage selectivity in its treatments, the company is conducting clinical trials with DNTH103 in several indications.

While we acknowledge the potential of DNTH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DNTH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

Page 9 of 9